About Us
Science
Therapeutic Areas
Media
Our Compliance Program
Contact Us

Explore Our Treatments

About Us
Science
Therapeutic Areas
Media
Our Compliance Program
Contact Us

Explore Our Treatments

Home
Media
News
Press Release

May 5, 2017

RADICAVA^™ (edaravone) Prescribing Information

RADICAVA (edaravone) Prescribing Information

Back to News

© 2024 Mitsubishi Tanabe Pharma America, Inc. All rights reserved.
CP-MTPA-US-0205 04/23

OUR COMPANY

About Us
Science
Therapeutic Areas

RESOURCES

Medical Inquiries
Our Compliance Program
Funding Requests

MEDIA

News
Media Assets

CONNECT WITH US

Facebook
Twitter
LinkedIn
Global Site
Contact Us
Careers

© 2024 Mitsubishi Tanabe Pharma America, Inc. All rights reserved.
CP-MTPA-US-0205 04/23

This information is intended for U.S. residents only

This information is intended for U.S. residents only

Terms of Use
Our Compliance Program
Privacy Policy
Expanded Access Policy
Our Policies
COVID-19
Sitemap

You are leaving this website, hosted by Mitsubishi Tanabe Pharma America, Inc.

This link will take you to a website to which our Privacy Policy and Terms of Use does not apply. Mitsubishi Tanabe Pharma America, Inc. does not control the content of this third-party site.

Continue

Cancel